Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$249.00
-4.84-1.91%
À la fermeture: -
$249.00
0.000.00%
Après les heures de négociation: Oct 17, 4:06 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Penumbra Inc a un objectif de cours consensus de $297.6, basé sur les évaluations des 20 analystes. Le plus élevé est de $350 attribué par Canaccord Genuity le juillet 30, 2025, et le plus bas est de $250 attribué par JP Morgan le février 23, 2024. Les 3 dernières évaluations d'analystes ont été publiées par Truist Securities, Needham et Evercore ISI Group le octobre 15, 2025, octobre 8, 2025 et octobre 7, 2025. Avec un objectif de cours moyen de $303.67 entre Truist Securities, Needham et Evercore ISI Group, il y a une variation implicite de 21.95% upside pour Penumbra Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Truist Securities
Needham
Evercore ISI Group
Morgan Stanley
Truist Securities
1calculé à partir des notes des analystes
Notes d'analystes pour Penumbra
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/15/2025 | 20.48% | Truist Securities | $310 → $300 | Maintains | Buy | |||
10/08/2025 | 30.92% | Needham | → $326 | Upgrade | Hold → Buy | |||
10/07/2025 | 14.46% | Evercore ISI Group | $300 → $285 | Maintains | Outperform | |||
09/02/2025 | 20.48% | Evercore ISI Group | → $300 | Initiates | → Outperform | |||
07/31/2025 | 6.83% | Morgan Stanley | $260 → $266 | Maintains | Equal-Weight | |||
07/30/2025 | 24.5% | Truist Securities | $300 → $310 | Maintains | Buy | |||
07/30/2025 | 34.54% | UBS | $330 → $335 | Maintains | Buy | |||
07/30/2025 | 30.52% | RBC Capital | $330 → $325 | Maintains | Outperform | |||
07/30/2025 | 14.46% | Baird | $283 → $285 | Maintains | Outperform | |||
07/30/2025 | 16.47% | Wells Fargo | $315 → $290 | Maintains | Overweight | |||
07/30/2025 | 40.56% | Canaccord Genuity | $340 → $350 | Maintains | Buy | |||
07/09/2025 | 14.46% | Citigroup | $320 → $285 | Maintains | Neutral | |||
04/24/2025 | 32.53% | RBC Capital | $315 → $330 | Maintains | Outperform | |||
04/24/2025 | 32.53% | UBS | $320 → $330 | Maintains | Buy | |||
04/24/2025 | 32.53% | Truist Securities | $315 → $330 | Maintains | Buy | |||
04/24/2025 | 27.71% | Stifel | $301 → $318 | Maintains | Buy | |||
04/24/2025 | 26.51% | Wells Fargo | $305 → $315 | Maintains | Overweight | |||
04/24/2025 | 30.52% | Baird | $316 → $325 | Maintains | Outperform | |||
04/11/2025 | 26.51% | Truist Securities | $325 → $315 | Maintains | Buy | |||
03/14/2025 | 28.51% | B of A Securities | → $320 | Initiates | → Buy | |||
02/19/2025 | 14.46% | JP Morgan | $230 → $285 | Maintains | Overweight | |||
02/19/2025 | 30.52% | Truist Securities | $285 → $325 | Maintains | Buy | |||
02/19/2025 | 25.7% | RBC Capital | $285 → $313 | Maintains | Outperform | |||
02/19/2025 | 36.55% | Canaccord Genuity | $323 → $340 | Maintains | Buy | |||
02/19/2025 | 28.51% | UBS | $305 → $320 | Maintains | Buy | |||
02/19/2025 | 22.49% | Wells Fargo | $275 → $305 | Maintains | Overweight | |||
02/19/2025 | 32.53% | Piper Sandler | $250 → $330 | Reiterates | Overweight → Overweight | |||
02/19/2025 | 4.42% | Morgan Stanley | $240 → $260 | Maintains | Equal-Weight | |||
02/19/2025 | 31.73% | Baird | $305 → $328 | Maintains | Outperform | |||
02/19/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
01/23/2025 | 22.49% | Baird | $275 → $305 | Maintains | Outperform | |||
01/21/2025 | 22.49% | UBS | → $305 | Initiates | → Buy | |||
12/18/2024 | 14.46% | RBC Capital | $232 → $285 | Maintains | Outperform | |||
12/18/2024 | 14.46% | Truist Securities | $240 → $285 | Maintains | Buy | |||
12/17/2024 | 10.44% | Oppenheimer | → $275 | Initiates | → Outperform | |||
12/11/2024 | -1.61% | Citigroup | $220 → $245 | Maintains | Neutral | |||
12/11/2024 | 10.44% | Wells Fargo | $190 → $275 | Upgrade | Equal-Weight → Overweight | |||
12/09/2024 | 29.72% | Canaccord Genuity | $260 → $323 | Maintains | Buy | |||
12/02/2024 | -3.61% | Morgan Stanley | $210 → $240 | Maintains | Equal-Weight | |||
11/26/2024 | 8.43% | BTIG | $232 → $270 | Maintains | Buy | |||
11/20/2024 | 0.4% | Piper Sandler | $235 → $250 | Maintains | Overweight | |||
11/04/2024 | 4.42% | Canaccord Genuity | $235 → $260 | Maintains | Buy | |||
10/31/2024 | -6.83% | RBC Capital | $222 → $232 | Maintains | Outperform | |||
10/31/2024 | -23.69% | Wells Fargo | $150 → $190 | Maintains | Equal-Weight | |||
10/31/2024 | -3.61% | Truist Securities | $235 → $240 | Maintains | Buy | |||
10/31/2024 | -6.83% | BTIG | $234 → $232 | Maintains | Buy | |||
10/31/2024 | -5.62% | Piper Sandler | $225 → $235 | Maintains | Overweight | |||
10/31/2024 | — | Needham | — | Reiterates | → Hold | |||
10/31/2024 | -0.4% | Baird | $244 → $248 | Maintains | Outperform | |||
10/25/2024 | — | Needham | — | Reiterates | → Hold | |||
10/18/2024 | -9.64% | Piper Sandler | $200 → $225 | Reiterates | Overweight → Overweight | |||
10/16/2024 | -5.62% | Canaccord Genuity | $176 → $235 | Maintains | Buy | |||
10/15/2024 | -2.01% | Baird | $180 → $244 | Maintains | Outperform | |||
10/14/2024 | -6.02% | BTIG | $224 → $234 | Maintains | Buy | |||
10/14/2024 | -5.62% | Truist Securities | $200 → $235 | Maintains | Buy | |||
10/08/2024 | -10.84% | RBC Capital | $205 → $222 | Maintains | Outperform | |||
09/17/2024 | -4.42% | Stifel | → $238 | Initiates | → Buy | |||
09/03/2024 | 5.62% | Leerink Partners | → $263 | Initiates | → Outperform | |||
08/28/2024 | -10.04% | BTIG | $187 → $224 | Maintains | Buy | |||
08/22/2024 | -19.68% | Citigroup | $178 → $200 | Maintains | Neutral | |||
07/31/2024 | -21.69% | Morgan Stanley | $210 → $195 | Maintains | Equal-Weight | |||
07/31/2024 | -24.9% | BTIG | $232 → $187 | Maintains | Buy | |||
07/31/2024 | -27.71% | Baird | $231 → $180 | Maintains | Outperform | |||
07/31/2024 | -17.67% | RBC Capital | $289 → $205 | Maintains | Outperform | |||
07/31/2024 | -19.68% | Truist Securities | $230 → $200 | Reiterates | Buy → Buy | |||
07/31/2024 | -19.68% | Piper Sandler | $260 → $200 | Maintains | Overweight | |||
07/31/2024 | -29.32% | Canaccord Genuity | $272 → $176 | Maintains | Buy | |||
07/31/2024 | -39.76% | Wells Fargo | $289 → $150 | Downgrade | Overweight → Equal-Weight | |||
07/31/2024 | -28.51% | Citigroup | $265 → $178 | Downgrade | Buy → Neutral | |||
07/31/2024 | — | Needham | — | Reiterates | → Hold | |||
07/16/2024 | -7.23% | Baird | $267 → $231 | Maintains | Outperform | |||
07/16/2024 | -7.63% | Truist Securities | $280 → $230 | Maintains | Buy | |||
07/15/2024 | -6.83% | BTIG | $265 → $232 | Maintains | Buy | |||
07/15/2024 | -15.66% | Morgan Stanley | $235 → $210 | Maintains | Equal-Weight | |||
07/10/2024 | 6.43% | Citigroup | $300 → $265 | Maintains | Buy | |||
05/08/2024 | -5.62% | Morgan Stanley | $240 → $235 | Maintains | Equal-Weight | |||
05/08/2024 | 9.24% | Canaccord Genuity | $284 → $272 | Maintains | Buy | |||
05/08/2024 | 4.42% | Piper Sandler | $290 → $260 | Maintains | Overweight | |||
05/08/2024 | — | Needham | — | Reiterates | → Hold | |||
04/17/2024 | 7.23% | Baird | $291 → $267 | Maintains | Neutral | |||
04/03/2024 | 16.47% | Piper Sandler | $290 → $290 | Reiterates | Overweight → Overweight | |||
03/22/2024 | 12.45% | Truist Securities | $290 → $280 | Maintains | Buy | |||
02/23/2024 | 16.06% | RBC Capital | $289 → $289 | Reiterates | Outperform → Outperform | |||
02/23/2024 | 16.47% | Piper Sandler | $310 → $290 | Reiterates | Overweight → Overweight | |||
02/23/2024 | 14.06% | Canaccord Genuity | → $284 | Reiterates | Buy → Buy | |||
02/23/2024 | 16.47% | Truist Securities | $300 → $290 | Maintains | Buy | |||
02/23/2024 | 0.4% | JP Morgan | $284 → $250 | Downgrade | Overweight → Neutral | |||
01/26/2024 | 20.48% | Truist Securities | $295 → $300 | Maintains | Buy | |||
01/12/2024 | 16.06% | RBC Capital | $280 → $289 | Maintains | Outperform | |||
01/11/2024 | 12.45% | RBC Capital | $248 → $280 | Maintains | Outperform | |||
12/22/2023 | 18.47% | Truist Securities | $265 → $295 | Maintains | Buy | |||
12/21/2023 | 14.06% | Canaccord Genuity | $207 → $284 | Maintains | Buy | |||
12/20/2023 | 14.06% | JP Morgan | $240 → $284 | Maintains | Overweight | |||
12/12/2023 | 6.43% | Truist Securities | $240 → $265 | Maintains | Buy | |||
11/03/2023 | 16.06% | Wells Fargo | $337 → $289 | Maintains | Overweight | |||
11/03/2023 | -3.61% | JP Morgan | $310 → $240 | Maintains | Overweight | |||
11/03/2023 | -16.87% | Canaccord Genuity | $322 → $207 | Maintains | Buy | |||
11/03/2023 | -2.41% | Baird | $247 → $243 | Maintains | Outperform | |||
11/03/2023 | 0.4% | Piper Sandler | $335 → $250 | Maintains | Overweight | |||
11/03/2023 | -3.61% | Morgan Stanley | $265 → $240 | Maintains | Equal-Weight |
FAQ
Quel est le cours indicatif de l'action Penumbra (PEN) ?
Le dernier objectif de prix pour Penumbra (NYSE:PEN) a été rapporté par Truist Securities le octobre 15, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $300.00 s'attendant à ce que PEN se rise dans les 12 prochains mois (un possible changement de 20.48% upside). 50 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Penumbra (PEN) ?
La dernière note d'analyste pour Penumbra (NYSE:PEN) a été fournie par Truist Securities, et Penumbra maintenu leur note buy.
Quand a eu lieu la dernière mise à niveau pour Penumbra (PEN) ?
La dernière amélioration pour Penumbra Inc a eu lieu le octobre 8, 2025 lorsque Needham a augmenté leur objectif de prix à $326. Needham avait précédemment a hold pour Penumbra Inc.
Quand a eu lieu la dernière dégradation pour Penumbra (PEN) ?
La dernière réduction pour Penumbra Inc a eu lieu le juillet 31, 2024 lorsque Wells Fargo a changé leur objectif de prix de $289 à $150 pour Penumbra Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Penumbra (PEN) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Penumbra, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Penumbra a été déposée le octobre 15, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 15, 2026.
La note d'analyste pour Penumbra (PEN) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Penumbra (PEN) était un maintenu avec un objectif de prix de $310.00 à $300.00. Le prix actuel de Penumbra (PEN) est de $249.00, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.